Advertisement

Topics

Immunicum AB IMMU Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

13:41 EST 14 Nov 2017 | BioPortfolio Reports

Summary


Immunicum AB Immunicum is a biopharmaceutical company that develops therapeutic for treatment of cancer. The company's products comprise INTUVAXRCC, INTUVAXHCC, SUBCUVAX and CD70. Immunicum's CD70 is in a preclinical phase studies. It has partnerships with biotech and pharmaceutical companies, INTUVAXRCC is a drug candidate used to treat Renal cell carcinoma, INTUVAXHCC is used for treating liver cancer and SUBCUVAX is a drug candidate, which induces a tumor specific immune reaction in vitro. The company uses technologies such as COMBIG and CD70 to develop therapeutic cancer vaccines. Immunicum is headquartered in Gothenburg, Sweden.


Immunicum AB Key Recent Developments


Oct 10,2017: Immunicum Announces Appointment of Sharon Longhurst as Head of CMC

Aug 18,2017: Immunicum: Interim Report Q2 Corporate Update and Outlook

May 19,2017: Immunicum: Quarterly Report JanuaryMarch 2017

Feb 17,2017: Immunicum: YearEnd Report 2016 July 2016 December 2016

Sep 27,2016: Immunicum Announces Carlos de Sousa as New CEO to take the Company to its Next Stage of Development


This comprehensive SWOT profile of Immunicum AB provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immunicum AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.


The profile contains critical company information including*,


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Note*: Some sections may be missing if data is unavailable for the company.


Key benefits of buying this profile include,


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Immunicum AB IMMU Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "Immunicum AB IMMU Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.